Top Markets
#1 Black Phoenix Black Phoenix +356.69%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +62.32%
#4 Gold Park Gold Park +57.04%
#5 Acurast Acurast +36.39%
#6 OpenEden OpenEden +29.86%
#7 BasedHype BasedHype +26.83%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.30%
#9 Cryptopia Cryptopia +21.54%
#10 Wibx Wibx +16.66%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rangering i aksjer #40869
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aksjekurs
$0.02765
Sist synkronisert: 2024-12-23
Markedsverdi
$69.04K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Kategori

Healthcare
Antall utestående aksjer for Histogen Inc. (HSTO)
Antall utestående aksjer per September 2023: 4.27M
Ifølge Histogen Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 4.27M. Ved slutten av December 2021 hadde selskapet 1.92M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Histogen Inc. (HSTO) fra 2011 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 4.27M 33.04%
2022 3.21M 67.41%
2021 1.92M 325.35%
2020 450.92K -23.66%
2019 590.69K 289.00%
2018 151.85K 6.24%
2017 142.93K 26.21%
2016 113.25K -99.39%
2015 18.62M 20.28%
2014 15.48M 110.37%
2013 7.36M 15,800.25%
2012 46.28K 0.00%
2011 46.28K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,843.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,355.65%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE